Hydromorphone 1.3mg capsules
BNF presentation 040702050AAAEAE within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
040702050AAAEAE
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
609
NHS spend (£)
£7,504.10
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 68 |
| February 2025 | 5 |
| December 2024 | 18 |
| November 2024 | 78 |
| October 2024 | 90 |
| August 2024 | 3 |
| July 2024 | 85 |
| May 2024 | 14 |
| July 2021 | 34 |
| June 2021 | 21 |
| December 2020 | 102 |
| November 2020 | 91 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 23 | No data available |
|
Atlantic Medical Group
ODS L82038
|
22 | 11N - CORNWALL & THE ISLES OF SCILLY ICB |
| Unknown pharmacy | 18 | No data available |
| Unknown pharmacy | 17 | No data available |
| Unknown pharmacy | 16 | No data available |
| Unknown pharmacy | 14 | No data available |
| Unknown pharmacy | 10 | No data available |
| Unknown pharmacy | 10 | No data available |
| Unknown pharmacy | 9 | No data available |
| Unknown pharmacy | 9 | No data available |